Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INSM INSMED Inc
- Stocks
- Healthcare
- NASDAQ: INSM
Price (delayed)
$65.08
Market cap
$11.85B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.93
Enterprise value
$12.76B
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved
Highlights
INSM's revenue is up by 21% year-on-year and by 4.8% since the previous quarter
The company's gross profit rose by 18% YoY and by 4.9% QoQ
The equity has soared by 121% YoY but it has plunged by 65% from the previous quarter
INSMED's net income has decreased by 36% YoY and by 11% QoQ
The EPS has declined by 13% year-on-year and by 6% since the previous quarter
Key stats
What are the main financial stats of INSM
Market
Valuations
Earnings
Shares outstanding
182.14M
Market cap
$11.85B
Enterprise value
$12.76B
Price to earnings (P/E)
N/A
Price to book (P/B)
118.79
Price to sales (P/S)
30.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
33.48
Revenue
$381.03M
Gross profit
$291.47M
Operating income
-$980.89M
Net income
-$1.01B
EBIT
-$923.79M
EBITDA
-$914.73M
Free cash flow
-$789.25M
Per share
Balance sheet
Liquidity
EPS
-$5.93
EPS diluted
-$5.93
Free cash flow per share
-$4.36
Book value per share
$0.55
Revenue per share
$2.11
TBVPS
$8.9
Total assets
$1.8B
Total liabilities
$1.7B
Debt
$1.31B
Equity
$99.16M
Working capital
$1.16B
Debt to equity
13.17
Current ratio
5.86
Quick ratio
5.21
Net debt/EBITDA
-0.99
Margins
Efficiency
Dividend
EBITDA margin
-240.1%
Gross margin
76.5%
Net margin
-265.9%
Operating margin
-257.4%
Return on assets
-52.7%
Return on equity
-447%
Return on invested capital
-45.8%
Return on capital employed
-59.1%
Return on sales
-242.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INSM stock price
How has the INSMED stock price performed over time
Intraday
-0.84%
1 week
-9.99%
1 month
-3.66%
1 year
146.7%
YTD
-5.74%
QTD
-14.69%
Financial performance
How have INSMED's revenue and profit performed over time
Revenue
$381.03M
Gross profit
$291.47M
Operating income
-$980.89M
Net income
-$1.01B
Gross margin
76.5%
Net margin
-265.9%
INSMED's operating income has decreased by 39% YoY and by 12% QoQ
INSMED's net income has decreased by 36% YoY and by 11% QoQ
INSM's revenue is up by 21% year-on-year and by 4.8% since the previous quarter
The company's gross profit rose by 18% YoY and by 4.9% QoQ
Price vs fundamentals
How does INSM's price correlate with its fundamentals
Growth
What is INSMED's growth rate over time
Valuation
What is INSMED stock price valuation
P/E
N/A
P/B
118.79
P/S
30.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
33.48
The EPS has declined by 13% year-on-year and by 6% since the previous quarter
The equity has soared by 121% YoY but it has plunged by 65% from the previous quarter
The price to book (P/B) is 2.2% higher than the last 4 quarters average of 116.2
INSM's price to sales (P/S) is 67% higher than its 5-year quarterly average of 18.5 but 9% lower than its last 4 quarters average of 34.0
INSM's revenue is up by 21% year-on-year and by 4.8% since the previous quarter
Efficiency
How efficient is INSMED business performance
INSM's ROE has soared by 58% from the previous quarter
The ROS has declined by 16% year-on-year and by 7% since the previous quarter
The ROIC has declined by 15% year-on-year
The company's return on assets rose by 7% YoY
Dividends
What is INSM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INSM.
Financial health
How did INSMED financials performed over time
INSM's total assets is 6% higher than its total liabilities
INSM's total assets has soared by 56% YoY but it is down by 11% QoQ
The current ratio has grown by 8% from the previous quarter
The debt to equity has soared by 187% from the previous quarter
The equity has soared by 121% YoY but it has plunged by 65% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.